Effect of Asymptomatic and Symptomatic COVID-19 on Acute Ischemic Stroke Revascularization Outcomes

Davide Strambo,João Pedro Marto,George Ntaios,Thanh N. Nguyen,Patrik Michel,Roman Herzig,Anna Członkowksa,Jelle Demeestere,Ossama Yassin Mansour,Georgios Georgiopoulos,Raul G. Nogueira,Alexander Salerno,Susanne Wegener,Philipp Baumgartner,Carlo W. Cereda,Giovanni Bianco,Morin Beyeler,Marcel Arnold,Emmanuel Carrera,Paolo Machi,Valerian Altersberger,Leo Bonati,Henrik Gensicke,Manuel Bolognese,Nils Peters,Stephan Wetzel,Marta Magriço,João Nuno Ramos,João Sargento-Freitas,Rita Machado,Carolina Maia,Egídio Machado,Ana Paiva-Nunes,Patrícia Ferreira,Teresa Pinho-e-Melo,Mariana Carvalho-Dias,André Paula,Manuel Alberto Correia,Pedro Castro,Elsa Azevedo,Luís Albuquerque,José Nuno-Alves,Joana Ferreira-Pinto,Torcato Meira,Liliana Pereira,Miguel Rodrigues,André Araújo,Marta Rodrigues,Mariana Rocha,Ângelo Pereira-Fonseca,Luís Ribeiro,Ricardo Varela,Manuel Cappellari,Cecilia Zivelonghi,Giulia Sajeva,Andrea Zini,Mauro Gentile,Stefano Forlivesi,Ludovica Migliaccio,Maria Sessa,Alessandro Pezzini,Davide Sangalli,Marialuisa Zedde,Rosario Pascarella,Susanna Diamanti,Simone Beretta,Ghil Schwarz,Giovanni Frisullo,Simona Marcheselli,Pierre Seners,Candice Sabben,Simon Escalard,Michel Piotin,Benjamin Maier,Guillaume Charbonnier,Fabrice Vuillier,Loic Legris,Pauline Cuisenier,Francesca R. Vodret,Gaultier Marnat,Jean-Sebastien Liegey,Igor Sibon,Fabian Flottmann,Gabriel Broocks,Nils-Ole Gloyer,Ferdinand O. Bohmann,Jan Hendrik Schaefer,Christian H. Nolte,Heinrich Audebert,Eberhard Siebert,Marek Sykora,Wilfried Lang,Julia Ferrari,Lukas Mayer-Suess,Michael Knoflach,Elke-Ruth Gizewski,Jeffrey Stolp,Lotte J. Stolze,Jonathan M. Coutinho,Paul J. Nederkoorn,Ido van-den-Wijngaard,Joke de Meris,Robin Lemmens,Sylvie De Raedt,Fenne Vandervorst,Matthieu Pierre Rutgers,Antoine Guilmot,Anne Dusart,Flavio Bellante,Patricia Calleja-Castaño,Fernando Ostos,Guillermo Gonzalez-Ortega,Paloma Martín-Jiménez,Sebastian García-Madrona,Antonio Cruz-Culebras,Rocio Vera,Maria-Consuelo Matute,Blanca Fuentes,María Alonso-de-Leciñana,Ricardo Rigual,Exuperio Díez-Tejedor,Soledad Pérez-Sánchez,Joan Montaner,Fernando Díaz-Otero,Natalia Perez de la Ossa,Belén Flores-Pina,Lucia Muñoz-Narbona,Angel Chamorro,Alejandro Rodríguez-Vázquez,Arturo Renú,Oscar Ayo-Martin,Francisco Hernandez-Fernandez,Tomas Segura,Herbert Tejada-Meza,Thant Hlaing,Isaiah See,Robert Simister,David J. Werring,Espen Saxhaug Kristoffersen,Annika Nordanstig,Katarina Jood,Alexandros Rentzos,Libor Šimůnek,Dagmar Krajíčková,Antonín Krajina,Robert Mikulík,Martina Cviková,Jan Vinklárek,David Školoudík,Martin Roubec,Eva Hurtikova,Rostislav Hrubý,Svatopluk Ostry,Ondrej Skoda,Marek Pernicka,Lubomír Kočí,Zuzana Eichlová,Martin Jíra,Martin Kovář,Michal Panský,Pavel Mencl,Hana Paloušková,Aleš Tomek,Petr Janský,Anna Olšerová,Martin Šrámek,Roman Havlíček,Petr Malý,Lukáš Trakal,Jan Fiksa,Matěj Slovák,Michał Karliński,Maciej Nowak,Halina Sienkiewicz-Jarosz,Anna Bochynska,Pawel Wrona,Tomasz Homa,Katarzyna Sawczynska,Agnieszka Slowik,Ewa Wlodarczyk,Marcin Wiącek,Izabella Tomaszewska-Lampart,Bartosz Sieczkowski,Halina Bartosik-Psujek,Marta Bilik,Anna Bandzarewicz,Malgorzata Dorobek,Justyna Zielińska-Turek,Marta Nowakowska-Kotas,Krystian Obara,Paweł Urbanowski,Sławomir Budrewicz,Maciej Guziński,Milena Świtońska,Iwona Rutkowska,Paulina Sobieszak-Skura,Beata Łabuz-Roszak,Aleksander Dębiec,Jacek Staszewski,Adam Stępień,Jacek Zwiernik,Grzegorz Wasilewski,Cristina Tiu,Elena-Oana Terecoasă,Razvan-Alexandru Radu,Anca Negrila,Bogdan Dorobat,Cristina Panea,Vlad Tiu,Simona Petrescu,Atilla Özcan-Özdemir,Mostafa Mahmoud,Hussam El-Samahy,Hazem Abdelkhalek,Jasem Al-Hashel,Ismail Ibrahim Ismail,Athari Salmeen,Abdoreza Ghoreishi,Sergiu Sabetay,Hana Gross,Piers Klein,Mohamad Abdalkader,Pascal Jabbour,Kareem El Naamani,Stavropoula Tjoumakaris,Rawad Abbas,Ghada-A. Mohamed,Alex Chebl,Jiangyong Min,Majesta Hovingh,Jenny Tsai,Muhib-A. Khan,Krishna Nalleballe,Sanjeeva Onteddu,Hesham E. Masoud,Mina Michael,Navreet Kaur,Laith Maali,Michael Abraham,Priyank Khandelwal,Ivo Bach,Melody Ong,Denis Babici,Ayaz-M. Khawaja,Maryam Hakemi,Kumar Rajamani,Vanessa Cano-Nigenda,Antonio Arauz,Pablo Amaya,Natalia Llanos,Akemi Arango,Miguel A. Vences,José-Domingo Barrientos,Rayllene Caetano,Rodrigo Targa,Sergio Scollo,Patrick Yalung,Shashank Nagendra,Abhijit Gaikwad,Kwon-Duk Seo

DOI: https://doi.org/10.1161/strokeaha.123.043899

IF: 10.17

2023-12-23

Stroke

Abstract:Stroke, Volume 55, Issue 1, Page 78-88, January 1, 2024. BACKGROUND:The association of COVID-19 with higher bleeding risk and worse outcomes in acute ischemic stroke (AIS) undergoing revascularization may be related to the presence of infection symptoms. We aimed to assess the safety and outcomes of revascularization treatments in patients with AIS with asymptomatic COVID-19 (AS-COVID) or symptomatic COVID-19 (S-COVID).METHODS:We conducted an international multicenter retrospective cohort study of consecutive AIS tested for SARS-CoV-2, receiving intravenous thrombolysis and endovascular treatment between 2020 and 2021. We compared COVID-negative controls, AS-COVID, and S-COVID using multivariable regression. We assessed symptomatic intracranial hemorrhage (symptomatic intracerebral hemorrhage), mortality, and 3-month disability (modified Rankin Scale score).RESULTS:Among 15 124 patients from 105 centers (median age, 71 years; 49% men; 39% treated with intravenous thrombolysis only; and 61% with endovascular treatment±intravenous thrombolysis), 849 (5.6%) had COVID-19, of whom 395 (46%) were asymptomatic and 454 (54%) symptomatic. Compared with controls, both patients with AS-COVID and S-COVID had higher symptomatic intracerebral hemorrhage rates (COVID-controls, 5%; AS-COVID, 7.6%; S-COVID, 9.4%; adjusted odds ratio [aOR], 1.43 [95% CI, 1.03–1.99]; aOR, 1.63 [95% CI, 1.14–2.32], respectively). Only in patients with symptomatic infections, we observed a significant increase in mortality at 24 hours (COVID-controls, 1.3%; S-COVID, 4.8%; aOR, 2.97 [95% CI, 1.76–5.03]) and 3 months (COVID-controls, 19.5%; S-COVID, 40%; aOR, 2.64 [95% CI, 2.06–3.37]). Patients with COVID-19 had worse 3-month disability regardless of disease symptoms although disability was affected to a greater extent in symptomatic patients (aOR for worse modified Rankin Scale score shift: AS-COVID, 1.25 [95% CI, 1.03–1.51]; S-COVID, 2.10 [95% CI, 1.75–2.53]). S-COVID had lower successful recanalization (74.9% versus 85.6%;P<0.001), first pass recanalization (20.3% versus 28.3%;P=0.005), and a higher number of passes.CONCLUSIONS:In AIS undergoing revascularization treatments, both AS-COVID and S-COVID influence the risk of intracranial bleeding and worse clinical outcomes. The magnitude of this effect is more pronounced in symptomatic infections, which also present less favorable recanalization outcomes. These findings emphasize the impact of SARS-CoV-2 infection on the prognosis of revascularized AIS independent of symptom status.REGISTRATION:URL:https://www.clinicaltrials.gov; Unique identifier: NCT04895462.

peripheral vascular disease,clinical neurology